Carbamylated darbepoetin (recombinant human erythropoietin) or darbepoetin (100 ng/ml) could decrease telomere shortening and senescence induced by TNF-α and uremic serum in EPCs from non-dialysis chronic kidney disease patients. The gene discussed is TNF; the disease is chronic kidney disease.